Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tacrolimus for chronic allergic conjunctivitis
IRCT201409248410N3Phase 2Completed
- Sponsor
- Arak University of Medical Sciences
- Start
- Jul 2011
- Modality
- RNA-Targeting Small Molecules → Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, single-arm trial of tacrolimus in allergic conjunctivitis (AC), sponsored by Arak University of Medical Sciences. Started Jul 2011; status: completed.
02
Drugs
tacrolimus
03
Conditions
allergic conjunctivitis (AC)
Beyond the preview
Go deeper on IRCT201409248410N3.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT201409248410N3.